TAMPA, Fla.--(BUSINESS WIRE)--The Orthopaedic Implant Company (“OIC”), announced the release of its anatomic lower extremity and straight plates today from its booth at The Orthopaedic Trauma Association’s annual meeting. The company’s largest product launch to date consists of distal fibula and tibia plates, proximal tibia plates, and straight compression and tubular plates.
The lower extremity and straight plates join OIC’s upper extremity plates, creating a comprehensive solution for addressing a multitude of small bone fragment indications. The OIC small frag plating system delivers variable angle and locking technology supported by a single set of instrumentation and screws. The utility and modularity of the set is designed to create instant surgeon familiarity across all small fragment indications, facilitate set-management, and deliver maximum value.
The system provides lag screw fixation for comminuted patterns, non-locking screws to obtain compression across simple patterns and locking fixation in osteopenic bone and multi-fragmentary fracture patterns.
“Small bone fractures constitute a large percentage of the orthopaedic trauma that comes through our country’s hospitals and surgery centers. In addressing these cases, OIC’s value proposition has never been more compelling,” said Itai Nemovicher, President and CEO of OIC.
About Orthopaedic Implant Company: OIC entered the medical device market in 2010 with an innovative approach to delivering the highest quality implants at the lowest possible price. OIC implants cost 50 to 60 percent less than the average market price of premium implants, saving health care systems millions of dollars a year. OIC’s high-quality, low-cost implants and products can be used for a variety of procedures, including treatment of orthopaedic trauma and spinal injuries. All OIC products are FDA approved and manufactured in FDA approved facilities.